In addition to TET2 and JAK2, somatic mutation in other regulatory genes, such as DNMT3A, TP53, and ASXL1, in CH, and their potential connection with the development of the atherosclerotic process, are subjects of daily study. The gene discussed is JAK2; the disease is cyclic hematopoiesis.